<unk> , sold under the brand name Kanuma, is a recombinant form of the enzyme lysosomal acid lipase (LAL) that is used as a medication for the treatment of lysosomal acid lipase deficiency (LAL-D). It is administered via intraveneous infusion. It was approved for medical use in the European Union and in the United States in 2015.
Sebelipase alfa
Asfotase alfa
Velmanase alfa
Cerliponase alfa
Angiozyme
Apetamin
Co-codaprin
Desmoteplase